This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
GeneRisk.com
Johnson, RobCase E-67Entrepreneurship, Innovation and ChangeA mediados del año 2000, los inversores en Medical Sciences Limited (MSL) consolidaron una nueva compañía, GeneRisk.com, para concentrar su capital en una herramienta de software propiedad de MSL. La inmediata cuestión planteada a los inversores de MSL fue cómo evaluar esta nueva compañía para la siguiente tanda de financiación.Starting at €8.20
-
GeneRisk.com
Johnson, RobCase E-67-EEntrepreneurship, Innovation and ChangeIn mid-2000 the investors in Medical Sciences Limited (MSL) set up a new company, GeneRisk.com, to capitalize on a proprietary software tool owned by MSL. The immediate issue facing MSL's investors was how to value this new company for the upcoming round of financing.Starting at €8.20
-
Tradetix Limited (B)
Johnson, RobCase E-204-EEntrepreneurship, FinanceThe (A) case describes a fast-growing company in the City of London whose CEO and board are considering initiating a trade sale process. The (B) case describes an offer received, which includes an earn-out as part of the price. The (C) case describes a sequence of events following acceptance of the offer-events that are totally unexpected and that jeopardize the earn-out.Starting at €5.74
-
Tradetix Limited (C)
Johnson, RobCase E-205-EEntrepreneurship, FinanceThe (A) case describes a fast-growing company in the City of London whose CEO and board are considering initiating a trade sale process. The (B) case describes an offer received, which includes an earn-out as part of the price. The (C) case describes a sequence of events following acceptance of the offer-events that are totally unexpected and that jeopardize the earn-out.Starting at €5.74
-
The Coffee Table
Johnson, Rob; Pinto, MauriceCase E-190-EEntrepreneurship, FinanceThis case describes how the entrepreneur financed an innovative coffee shop chain from start-up through multiple stages of growth. The company raised £12.6 million over six rounds of financing and needs another £9-11 million at the end of the case. The entrepreneur must decide whether (a) to press ahead with another round of capital to fund further expansion, (b) to stop opening new shops and focus on becoming profitable, or (c) to sell the com...Starting at €8.20
-
Accolade Group
Kolarova, Lenka; Johnson, RobCase E-225-EFinanceIn September 2005, John Allen, the Chairman and founder of Accolade Group, leaned back in the armchair in his office and reflected on the developments in his company over the past nine years. Allen had a lifelong career in the UK leisure industry, culminating in his founding of the Accolade Group through a £279m management buy-in (MBI) of the Accolade Bingo business from Guss, a quoted UK-based leisure company, in 1997. Allen had a vision that un...Starting at €8.20
-
Aphrodite Partners versus Cashmine Capital Partners: Regulation Attempts in a Private Industry
Grabenwarter, Uli; Campisi, Sergio; Liechtenstein, HeinrichCase F-842-EEconomics, FinanceThis case deals with transparency and disclosure policies of GPs in the interaction with their investor base and serves as a discussion base for the question, whether Fund management activities in Private Equity should be subject to higher scrutiny and/or financial market regulation. The case projects this industry four years into the future, inviting students to suggest possible conclusions from the ongoing debate on higher regulatory oversight...Starting at €8.20
-
Tradetix Limited (A)
Johnson, RobCase E-203-EEntrepreneurship, FinanceThe (A) case describes a fast-growing company in the City of London whose CEO and board are considering initiating a trade sale process. The (B) case describes an offer received, which includes an earn-out as part of the price. The (C) case describes a sequence of events following acceptance of the offer-events that are totally unexpected and that jeopardize the earn-out.Starting at €8.20